Chemotherapy_bottles_NCI

SHOCKING: Berkeley Doctor Says More People Die from Chemotherapy than from Cancer [VIDEO]

Dr. Hardin B. Jones, a former professor of medical physics and physiology at the University of California, Berkeley, claims that ‘leading edge’ cancer treatments are a sham. And, that more people die from chemotherapy than from cancer.

Dr. Jones states that people who refuse chemotherapy, live on average, 12.5 years longer than people who undergo chemotherapy. He adds that, chemotherapy doesn’t work 97 percent of the time.

In a recently published study, by the New York Academy of Science, Dr. Jones writes,

“People who refused chemotherapy treatment live on average 12 and a half years longer than people who are undergoing chemotherapy. People who accepted chemotherapy die within three years of diagnosis, a large number dies immediately after a few weeks.”

He adds that the primary reason doctors prescribe chemotherapy is to make money. On average, cancer treatments cost between $300,000 and one million dollars per treatment.

Dr. Jones adds, “Patients with breast cancer who reject conventional therapy live four times longer than those who follow the system. So this is something that you will not hear in the mass media, which will continue to carry the myth that the best chemotherapy drug in the fight against cancer.”

Tags

Bethany Blankley

Bethany Blankley is a political analyst for Fox News Radio and has appeared on television and radio programs nationwide. She writes about political, cultural, and religious issues in America from the perspective of an evangelical and former communications staffer. She was a communications strategist for four U.S. Senators, one U.S. Congressman, a former New York governor, and several non-profits. She earned her MA in Theology from The University of Edinburgh, Scotland and her BA in Political Science from the University of Maryland. Follow her @bethanyblankley facebook.com/BlankleyBethany/ & BethanyBlankley.com.

Please leave your comments below

Facebook Comments

Disqus Comments